These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21798460)

  • 41. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
    Perkins RB; Legler A; Hanchate A
    Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The HPV infection in males: an update.
    Giraldi G; De Luca d'Alessandro E
    Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What can surveillance of genital warts tell us?
    Fairley CK; Donovan B
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
    Joura EA; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch X; Dillner J; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Lu S; Vuocolo S; Hesley TM; Haupt RM; Barr E
    Vaccine; 2008 Dec; 26(52):6844-51. PubMed ID: 18930097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of human papillomavirus vaccine in reducing genital warts: A Google Trends analysis.
    Simonart T; Lam Hoai XL; De Maertelaer V
    J Am Acad Dermatol; 2022 Apr; 86(4):956-958. PubMed ID: 33812953
    [No Abstract]   [Full Text] [Related]  

  • 47. Human papillomavirus typing in reporting of condyloma.
    Sturegård E; Johansson H; Ekström J; Hansson BG; Johnsson A; Gustafsson E; Dillner J; Forslund O
    Sex Transm Dis; 2013 Feb; 40(2):123-9. PubMed ID: 23324975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination.
    Lehtinen M; Apter D
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):326-32. PubMed ID: 26308204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human papillomavirus, genital warts, and vaccines.
    Hsueh PR
    J Microbiol Immunol Infect; 2009 Apr; 42(2):101-6. PubMed ID: 19597640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HPV vaccine strategies: the cost of HPV and the choice of vaccine.
    Morris SR
    Sex Transm Infect; 2009 Sep; 85(5):315-6. PubMed ID: 19773455
    [No Abstract]   [Full Text] [Related]  

  • 51. HPV vaccine against HPV infection and disease in males.
    Wieland U; Kreuter A
    N Engl J Med; 2011 Jun; 364(22):2163; author reply 2164-5. PubMed ID: 21631334
    [No Abstract]   [Full Text] [Related]  

  • 52. Post-licensure monitoring of HPV vaccine in the United States.
    Markowitz LE; Hariri S; Unger ER; Saraiya M; Datta SD; Dunne EF
    Vaccine; 2010 Jul; 28(30):4731-7. PubMed ID: 20188681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Start early to prevent genital HPV infection-and cervical cancer.
    Heavey E
    Nursing; 2008 May; 38(5):62-3. PubMed ID: 18431214
    [No Abstract]   [Full Text] [Related]  

  • 54. HPV vaccine update: new indications and controversies.
    Mendoza N; Hernandez PO; Tyring SK
    Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How to best measure the effectiveness of male human papillomavirus vaccine programmes?
    Garland SM; Molesworth EG; Machalek DA; Cornall AM; Tabrizi SN
    Clin Microbiol Infect; 2015 Sep; 21(9):834-41. PubMed ID: 26055415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HPV vaccine and its recommendations, 2007.
    Zimmerman RK
    J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S1-5, C1. PubMed ID: 17270106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Random Network Models to Predict the Long-Term Impact of HPV Vaccination on Genital Warts.
    Díez-Domingo J; Sánchez-Alonso V; Villanueva RJ; Acedo L; Moraño JA; Villanueva-Oller J
    Viruses; 2017 Oct; 9(10):. PubMed ID: 29035332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What about vaccinating women with cervical intraepithelial neoplasia against human papillomavirus infection?
    Gupta N
    BMJ; 2013 Jun; 346():f3733. PubMed ID: 23757747
    [No Abstract]   [Full Text] [Related]  

  • 60. [The human papillomavirus vaccine: is it of value in dermatology?].
    Pedragosa-Jové R; Salleras-Redonet M;
    Actas Dermosifiliogr; 2012 Mar; 103(2):92-3. PubMed ID: 22296714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.